IIC
GILD icon

Integrated Investment Consultants’s Gilead Sciences GILD Stock Holding History

Integrated Investment Consultants’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,240
Closed -$696K – 598
2016
Q1 		$696K Hold
7,240
– – 0.4% 41
2015
Q4 		$665K Buy
+7,240
New +$753K 0.52% 35

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integrated Investment Consultants's GILD Position: Q2 2016 in Review

Integrated Investment Consultants sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 7,240 shares — an estimated $696K sold.

Integrated Investment Consultants first reported a position in GILD in Q4 2015 and held it in 2 quarters. The position peaked at $696K in Q1 2016. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Integrated Investment Consultants reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Integrated Investment Consultants sold 7,240 Gilead Sciences shares in Q2 2016, an estimated $696K.
  • Integrated Investment Consultants first reported a position in Gilead Sciences in Q4 2015 and held it in 2 quarters.
  • Integrated Investment Consultants's Gilead Sciences position peaked at $696K in Q1 2016.
  • 1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Integrated Investment Consultants's 13F filing for Q2 2016, filed 5 Jul 2016.